Jaipur, Oct. 5 -- Three people, including a doctor, fell ill and were hospitalised in Bharatpur district on Saturday after they allegedly consumed Dextromethorphan HBr cough syrup amid reports of child deaths caused by consumption of contaminated cough syrups in Rajasthan and neighbouring Madhya Pradesh, officials aware of the details said. The development comes a day after the Rajasthan government banned the distribution of all cough syrups containing Dextromethorphan in the state over concerns the of drug being linked to the death of three children in the state. According to officials, three new cases involving the drug was reported in Bharatpur on Saturday. The list of hospitalised individuals include Rama Devi (60), a resident of Gundwa village in Bharatpur's Sewar, who was admitted to the Raj Bahadur Memorial hospital by her family on Saturday. According to officials, the woman's grandson had fallen sick few days ago and he was taken to the Satelite Hospital in Bharatpur, where a doctor prescribed him two bottles of Dextromethorphan HBr Syrup IP 13.5mg/5ml and some other tablets. "She bought two bottles of the cough syrup, which she and her grandson claimed to have consumed after being prescribed by a local doctor 10 days ago," said Bharatpur chief medical and health officer (CMHO) Dr Gaurav Kapoor. According to Rama Devi, her grandson first vomited and suffered from dehydration after consuming the medicine. "We thought he was unable to digest it as he is a child. On Friday night, I also used the same syrup after having cough and started vomiting relentlessly and eventually fainted. My family brought me to the hospital for treatment," she said. Kapoor suspected the syrup was linked to the woman's condition, adding that a sample of the medicine was sent for testing. Similarly, a doctor at the Kalsada Community Health Centre fell ill on Saturday after he consumed the cough syrup after family members of a child, who was brought to him, claimed the minor's sickness was linked to the medicine. Dr Tara Chand Yogi, while being treated at the hospital, said, "The child was brought to my centre by his parents. They claimed that he vomited badly after having the syrup. I consumed it immediately in front of them to check." At first, he did not face any problems. "But, I fainted a while later and was admitted to the Bayana hospital by my colleagues," he said, adding that the condition of the sick child in question has since improved and is stable. "The child is safe now. He was not needed to be hospitalised. We have changed his syrup." An 18-year-old was also hospitalised in Bharatpur and later referred to Jaipur after consuming the Dextromethorphan HBr cough syrup on Saturday. Shailendra Singh, a resident of Basiyan Kalan village, was hospitalised after facing difficulties in breathing. "He was admitted to the Intensive Care Unit ward but doctors referred him to Jaipur due to a problem in his respiratory system," CMHO Kapoor said. "According to his family members, his father bought the cough syrup around seven days ago from the Lakhanpur Community Health Centre and his son consumed it and fell sick." The Rajasthan government, in a press conference on Saturday, said that the state was investigating reports of Dextromethorphan cough syrup allegedly causing the deaths of three children in the state over the last month. Health minister Gajendra Singh Khimsar said that a complaint was first received through departmental officials on September 28, 2025, regarding batch number KL-25/147 of the Dextromethorphan HBr Syrup IP 13.5mg/5ml from Bharatpur, and on September 29 regarding batch number KL-25/148 of the same drug from Sikar district. He said that initial complaints were that patients using the syrup experienced vomiting, drowsiness, anxiety, dizziness, restlessness, and unconsciousness. Upon receiving the complaints, the department immediately banned the distribution and use of the affected batches. Statutory samples of these batches were also taken and sent to the State Drug Testing Laboratory for quality testing. Based on preliminary investigation, Khimsar said that doctors had not prescribed or administered Dextromethorphan HBr cough syrup in all three cases, adding that there was no record of the children receiving the drug at any government hospital. In the wake of the deaths, six samples of the drug, manufactured by Kaysons Pharma, was sent for testing, the minister said, adding that reports of the testing revealed that the samples were of standard quality. One hundred thirty-three thousand doses of this drug have been distributed from the referenced batches, and no complaints or adverse reports have been received. Despite this, as a precaution, the department has suspended the use and distribution of all 19 types of drugs supplied by the firm, including the cough syrup, until further orders....